Beyond Air

$5.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-0.38%) Today
$0.00 (0.00%) As of 6:00 PM EST after-hours

Why Robinhood?

You can buy or sell Beyond Air and other stocks, options, and ETFs commission-free!

About XAIR

Beyond Air, Inc. Common Stock, also called Beyond Air, is a clinical-stage medical device and biopharmaceutical company. It engages in the developing a nitric oxide generator and delivery system that uses nitric oxide generated from ambient air and delivers precise amounts of nitric oxide to the lungs for the potential treatment of respiratory and other diseases. The company develops LungFit platform system, a generator and delivery system that produces nitric oxide from ambient air, eliminating the need for expensive and cumbersome cylinders. Beyond Air was founded in 2011 and is headquartered in Garden City, NY. The listed name for XAIR is Beyond Air, Inc. Common Stock.

CEO
Steven A. Lisi
Employees
23
Headquarters
Garden City, New York
Founded
2011
Market Cap
92.10M
Price-Earnings Ratio
Dividend Yield
Average Volume
296.61K
High Today
$5.42
Low Today
$5.26
Open Price
$5.31
Volume
133.35K
52 Week High
$12.50
52 Week Low
$3.45

Collections

XAIR Earnings

-$0.67
-$0.31
$0.05
$0.41
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
-$0.30 per share
Actual
-$0.30 per share

You May Also Like